13th April 2012
PRIMA BIOMED TO LIST ON NASDAQ ON APRIL 16
Australian healthcare company Prima BioMed Ltd (ASX: PRR, NASDAQ:PBMD) (Prima) is pleased to announce that it will commence trading on the NASDAQ Stock Market (NASDAQ) of American Depositary Receipts (ADR), on Monday, April 16, 2012 U.S. Eastern Time.
Upon listing on the NASDAQ, the Company will have dual listings of its securities on both the Australian Securities Exchange (ASX) and NASDAQ.
Every one ADR will represent 30 ordinary fully paid shares. Prima’s NASDAQ listing is a Level II ADR compliance listing, and will be managed by Bank of New York Mellon.
Bank of New York Mellon will be Prima’s deposit agent for converting the Company’s common shares into ADRs. Deutsche Bank Securities Inc., Noble Financial Capital Markets and Aegis Capital are market makers for Prima in the United States.
A registration statement relating to the ADR’s has been filed with, and declared effective by, the U.S. Securities and Exchange Commission.
- Forums
- ASX - By Stock
- IMM
- to list on 16th
to list on 16th, page-3
-
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
(20min delay)
|
|||||
Last
40.0¢ |
Change
-0.005(1.23%) |
Mkt cap ! $581.0M |
Open | High | Low | Value | Volume |
41.0¢ | 41.5¢ | 39.5¢ | $1.576M | 3.906M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2506 | 39.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
40.0¢ | 8079 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 62000 | 0.390 |
4 | 33064 | 0.385 |
8 | 91570 | 0.380 |
1 | 100000 | 0.370 |
4 | 24220 | 0.360 |
Price($) | Vol. | No. |
---|---|---|
0.410 | 41895 | 3 |
0.415 | 130388 | 7 |
0.420 | 550003 | 10 |
0.425 | 39700 | 3 |
0.430 | 13701 | 3 |
Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online